Julia von Tresckow

ORCID

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 8

Top Venues

European journal of haematology

Annals of hematology

Leukemia

Hematological oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Melina Sophie Kurte, Ann-Cathrine Siefen, Florian Jakobs, Tabea Poos, Julia von Tresckow, Bastian von Tresckow, Hans Christian Reinhardt, Florian Kron
Time-dependent cost comparison and health economic impact analysis of second-line interventions for transplant-ineligible patients with relapsed or refractory diffuse large B cell lymphoma. European journal of haematology 113 (3) (2024)
Melina Sophie Kurte, Ann-Cathrine Siefen, Florian Jakobs, Tabea Poos, Julia von Tresckow, Bastian von Tresckow, Hans Christian Reinhardt, Florian Kron
Time-dependent cost comparison and health economic impact analysis of second-line interventions for transplant-ineligible patients with relapsed or refractory diffuse large B cell lymphoma. European journal of haematology (2024)
Nadine Kutsch, Adam Giza, Sandra Robrecht, Janina Stumpf, Anno Federhen, Andrea Stoltefuß, Ursula Vehling-Kaiser, Michael Koenigsmann, Eugen Tausch, Christof Schneider, Stephan Stilgenbauer, Thomas Illmer, Rudolf Schlag, Steffen Dörfel, Tobias Gaska, Michael Kiehl, Sigrun Müller-Hagen, Enno Moorahrend, Hartmut Linde, Anke Schlenska-Lange, Julia von Tresckow, Kirsten Fischer, Barbara Eichhorst, Michael Hallek, Anna Maria Fink
Fludarabine, cyclophosphamide, and rituximab as first-line treatment in patients with chronic lymphocytic leukemia: A long-term analysis of the German CLL Study Group (GCLLSG) registry. European journal of haematology (2024)
Nadine Kutsch, Adam Giza, Sandra Robrecht, Janina Stumpf, Anno Federhen, Andrea Stoltefuß, Ursula Vehling-Kaiser, Michael Koenigsmann, Eugen Tausch, Christof Schneider, Stephan Stilgenbauer, Thomas Illmer, Rudolf Schlag, Steffen Dörfel, Tobias Gaska, Michael Kiehl, Sigrun Müller-Hagen, Enno Moorahrend, Hartmut Linde, Anke Schlenska-Lange, Julia von Tresckow, Kirsten Fischer, Barbara Eichhorst, Michael Hallek, Anna Maria Fink
Fludarabine, cyclophosphamide, and rituximab as first-line treatment in patients with chronic lymphocytic leukemia: A long-term analysis of the German CLL Study Group (GCLLSG) registry. European journal of haematology 113 (2) (2024)
Julia von Tresckow, Nikola Heyl, Sandra Robrecht, Adam Giza, Ali Aldaoud, Rudolf Schlag, Martine Klausmann, Hartmut Linde, Wolfgang Stein, Andreas Schwarzer, Kirsten Fischer, Paula Cramer, Barbara Eichhorst, Michael Hallek, Anna Maria Fink
Treatment with idelalisib in patients with chronic lymphocytic leukemia - real world data from the registry of the German CLL Study Group. Annals of hematology (2023)
Julia von Tresckow, Paula Cramer, Sandra Robrecht, Petra Langerbeins, Anna-Maria Fink, Othman Al-Sawaf, Moritz Fürstenau, Thomas Illmer, Holger Klaproth, Eugen Tausch, Matthias Ritgen, Kirsten Fischer, Clemens-Martin Wendtner, Karl-Anton Kreuzer, Stephan Stilgenbauer, Sebastian Böttcher, Barbara F Eichhorst, Michael Hallek
Sequential treatment with bendamustine, obinutuzumab (GA101) and Ibrutinib in chronic lymphocytic leukemia (CLL): final results of the CLL2-BIG trial. Leukemia 36 (8) (2022)
Fabian Ullrich, Christine Hanoun, Amin T Turki, Tobias Liebregts, Katharina Breuckmann, Ferras Alashkar, Hans Christian Reinhardt, Bastian von Tresckow, Julia von Tresckow
Early report on the severity of COVID-19 in hematologic patients infected with the SARS-CoV2 omicron variant. European journal of haematology 109 (4) (2022)
Christian Hoffmann, Philipp Rating, Nikolaos Bechrakis, Anja Eckstein, Ekaterina Sokolenko, Leyla Jabbarli, Henrike Westekemper, Christopher Mohr, Claus Schmeling, Andreas Huettmann, Julia von Tresckow, Sophia Göricke, Cornelius Deuschl, Patricia Johansson, Christoph Pöttgen, Thomas Gauler, Nika Guberina, Sourour Moliavi, Martin Stuschke, Maja Guberina
Long-term follow-up and health-related quality of life among cancer survivors with stage IEA orbital-type lymphoma after external photon-beam radiotherapy: Results from a longitudinal study. Hematological oncology (2022)

Julia von Tresckow.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Julia von Tresckow